This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Floris van Delft, PhD
Founder and Chief Scientific Officer at SynAffix BV


PhD (1996, cum laude) from Leiden University in carbohydrate chemistry and stereoselective synthesis postdoctoral research at the Scripps Research Institute (K.C. Nicolaou), total synthesis of complex natural product Assistant/associate professor at University of Amsterdam (1998-1999) and Radboud University Nijmegen (2000-2013), focus on click chemistry and protein conjugation technologies. 

Floris van Delft is co-founder and CSO of Synaffix, as well as special professor in 'Bioconjugate Chemistry' at Wageningen University. He has authored >150 peer-reviewed publications and is co-inventor on >25 patent applications.

Agenda Sessions

  • Clinical Stage GlycoConnect™ Technology based on Glycan Remodeling-Conjugation as a Powerful Platform for ADC and Bispecific Antibody Generation

    On Demand
  • LIVE Moderated Panel Discussion and Q&A Including Audience Interaction with Speakers from On-Demand SESSION #8: POTENTIATING ANTIBODIES THROUGH CONJUGATION - To prepare for this discussion/Q&A, attendees should view the presentations from Session #8 in the Watch On-Demand Sessions Tab prior to this session